Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,655 | 7,563 | 9,292 | 11,828 | 11,545 |
| Marketable Securities | N/A | N/A | N/A | 25 | 25 |
| Other current assets | 0 | 551 | 0 | 0 | 0 |
| TOTAL | $9,955 | $8,406 | $10,151 | $12,053 | $11,884 |
| Non-Current Assets | |||||
| Investments And Advances | 37 | 37 | 37 | 33 | 33 |
| Other Non-Current Assets | 41 | 48 | 55 | 0 | 0 |
| TOTAL | $78 | $85 | $93 | $33 | $33 |
| Total Assets | $10,033 | $8,491 | $10,243 | $12,086 | $11,917 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 333 | 361 | 36 | 707 | 521 |
| Accrued Expenses | 317 | 250 | 614 | 872 | 1,195 |
| TOTAL | $681 | $640 | $679 | $1,579 | $1,716 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11 | 19 | 26 | 0 | 250 |
| TOTAL | $11 | $19 | $26 | $N/A | $250 |
| Total Liabilities | $692 | $659 | $705 | $1,579 | $1,966 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,904 | 4,889 | 4,404 | 4,346 | 3,302 |
| Common Shares | 1 | 0 | 0 | 0 | 0 |
| Retained earnings | -56,618 | -54,985 | -52,222 | -51,242 | -49,156 |
| Other shareholders' equity | 23 | 22 | 27 | 23 | -24 |
| TOTAL | $9,341 | $7,833 | $9,538 | $10,507 | $9,951 |
| Total Liabilities And Equity | $10,033 | $8,491 | $10,243 | $12,086 | $11,917 |